Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer’s Disease

Dysbiosis contributes to Alzheimer’s disease (AD) pathogenesis, and oral bacteriotherapy represents a promising preventative and therapeutic opportunity to remodel gut microbiota and to delay AD onset and progression by reducing neuroinflammation and amyloid and tau proteins aggregation. Specificall...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfili, Laura, Gong, Chunmei, Lombardi, Francesca, Cifone, Maria Grazia, Eleuteri, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745493/
https://www.ncbi.nlm.nih.gov/pubmed/35008786
http://dx.doi.org/10.3390/ijms23010357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745493/
https://www.ncbi.nlm.nih.gov/pubmed/35008786
http://dx.doi.org/10.3390/ijms23010357

Ejemplares similares